Inhibitor Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Inhibitor Therapeutics, Inc. (INTI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 10.77 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 10.77M shares.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 0.00 shares.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 1.62M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|
| 2022-12-31 | 10.77M shares 10-K · filed 2024-03-29 |
| 2021-12-31 | 0.00 shares 10-K · filed 2022-03-30 |
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-30 |
| 2019-12-31 | 1.62M shares 10-K · filed 2021-03-26 |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-30 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-02-16 |
| 2013-12-31 | 245.44K shares 10-K · filed 2015-02-13 |